Fruquintinib Plus PD-1 in Refractory MSS Metastatic Colorectal Cancer
收藏NIAID Data Ecosystem2026-03-10 收录
官方服务：
资源简介：
The survival of the refractory CRC is dismal and therapy options are limited ，the researchers aim to investigate the efficacy, safety, and predictors of fruquintinib plus PD-1 in refractory MSS metastatic colorectal cancer in a real-world setting.
创建时间：
2019-01-15
